Press release
Epirubicin Market Revenue to Cross US$ 243.99 million by 2028 : Premium Market Insights
Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial and 200mg/Vial), Application (Breast cancer, Liver Cancer, Bladder Cancer, and Others), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies) The global epirubicin market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028.Get PDF Sample Report + All Related Table and Graphs @: https://www.premiummarketinsights.com/sample/TIP00073584
Competitive Landscape: Epirubicin Market:
Epirubicin hydrochloride is a class of drugs termed anthracyclines and is primarily used to treat breast cancers after surgical resection. Anthracyclines are antibiotics isolated from the gram-positive bacteria Streptomyces. They are commonly used as chemotherapy agents and exert their antineoplastic effects by targeting the replication of DNA. Epirubicin HCl is often preferred over anthracycline doxorubicin as it has been shown to have fewer side effects. Epirubicin HCl became FDA-approved (Food and Drug Administration) as adjuvant therapy for treating axillary node-positive breast cancers following resection under the trade name Ellence in 1999.
The growing pharmaceutical industry worldwide is also likely to create growth opportunities for the epirubicin market. The US pharmaceutical market is the largest and the most commercial market in North America. The US alone holds over 45% of the global pharmaceutical market. The majority of the top global drug manufacturing companies are from the US, and the nation has been at the forefront of biomedical research.
Pfizer, Inc.
Teva Pharmaceutical Industries Ltd.
Salius Pharma Pvt Ltd
Areva Pharmaceuticals Mylan N. V.
Hikma Pharmaceuticals PLC
Fresenius Kabi AG
Miracalus Pharma Pvt. Ltd.
Bottom of Form
Chapter Details of Epirubicin Market:
Part 01: Executive Summary
Part 02: Scope of The Report
Part 03: Epirubicin Market Landscape
Part 04: Epirubicin Market Sizing
Part 05: Epirubicin Market Segmentation by Product
Part 06: Five Forces Analysis
Part 07: Customer Landscape
Part 08: Geographic Landscape
Part 09: Decision Framework
Part 10: Drivers and Challenges
Part 11: Market Trends
Part 12: Vendor Landscape
Part 13: Vendor Analysis
Interested in Purchasing this Report? Click here @ https://www.premiummarketinsights.com/buy/TIP00073584
Contact Us:
If you have any queries about this report or if you would like further information, please contact us:
Contact Person: Ankit Mathur
E-mail: sales@permiummarketinsights.com
Phone: +1-646-491-9876
About Us:
Premium Market Insights is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers.
The market research industry has changed in last decade. As corporate focus has shifted to niche markets and emerging countries, a number of publishers have stepped in to fulfil these information needs. We have experienced and trained staff that helps you navigate different options and lets you choose best research solution at most effective cost.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Epirubicin Market Revenue to Cross US$ 243.99 million by 2028 : Premium Market Insights here
News-ID: 3646817 • Views: …
More Releases from Premium Market Insights
North America Overhead Cranes Market could be worth US$ 1,020.54 million by 2028 …
The North America overhead cranes market is expected to grow from US$ 1,020.54 million in 2022 to US$ 1,558.94 million by 2028. It is estimated to grow at a CAGR of 7.3% from 2022 to 2028. Analysis By Type (Gantry Crane, Bridge Crane, Jib Crane, Monorail Crane, and Others), Installation (Mobile Crane and Fixed Crane), Operation Type (Electric, Hydraulic, and Hybrid), and Verticals (Logistics, Automotive, Marine, and Others)
Get PDF Sample…
Commercial Refrigeration Market to exceed US$ US$ 28.8 billion by 2030, says Pre …
The Commercial Refrigeration Market size is expected to grow from US$ 28.8 billion in 2022 and is expected to reach US$ 49.0 billion by 2030; it is estimated to record a CAGR of 6.9% from 2022 to 2030.Commercial Refrigeration Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type (Refrigerator, Freezer, Heated Cabinets, Milk Coolers, Chef Bases, Full Size Undercounters,…
Coagulation Market could be worth 6,295.28 million by 2030,,says Premium Market …
The coagulation market is expected to grow from US$ 6,295.28 million in 2022 to US$ 10,853.28 million by 2030; it is anticipated to record a CAGR of 7.0% from 2022 to 2030.Coagulation Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Disease Indications (Vitamin K Deficiency, Liver Disease, Disseminated Intravascular Coagulation & Pulmonary Embolism, Development of Circulating Anticoagulants, Hemophilia, Von…
Bread Market to Hit US$ 350.17 billion by2030 ; Premium Market Insights
The bread market was valued at US$ 266.33 billion in 2022 and is projected to reach US$ 350.17 billion by 2030; it is expected to register a CAGR of 3.4% from 2022 to 2030.Bread Market Forecast to 2030 - COVID-19 Impact and Global Analysis By Type (Loaves, Sandwich Bread, Baguettes, Burger Buns, and Others); Category (Organic and Conventional); Distribution Channel (Supermarkets and Hypermarkets, Specialty Stores, Online Retail, and Others)
Get PDF…
More Releases for Epirubicin
Epirubicin Market Estimated to Experience a Hike in Growth by 2028
Epirubicin Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the market dynamics.
Download…
Epirubicin Market could be worth US$ 243.99 million by 2028 , says Premium Marke …
Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Dosage (10mg/Vial, 50mg/Vial, 100mg/Vial and 200mg/Vial), Application (Breast cancer, Liver Cancer, Bladder Cancer, and Others), and Distribution Channel (Hospitals Pharmacies, Retail Pharmacies, and Online Pharmacies) The global epirubicin market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028..
Get…
North America Epirubicin Market Report by Worldwide Market Trends & Opportunitie …
The North America epirubicin market is expected to grow from US$ 95,445.28 thousand in 2022 to US$ 1,18,596.58 thousand by 2028; it is estimated to grow at a CAGR of 3.7% from 2022 to 2028.
North America Epirubicin Market 2022 - 2028 report offers insights into the newest growth and trends. It summarizes crucial aspects of the market, with target on leading key player's areas that have witnessed the highest demand,…
Epirubicin Market Is Expected To Reach at US$ 282.81 Mn By 2032
The market for epirubicin is projected to expand at a CAGR of 3.6% over the course of the forecast period and will likely reach US$ 198.56 Million in 2022. By 2032, it is expected that epirubicin sales will surpass US$ 282.81 million.
The increased prevalence of breast cancer is expected to increase epirubicin sales as well. Throughout the world, there are more cancer cases among women. According to the World Health…
Epirubicin Market Comprehensive Analysis and Future Estimations by 2028
The global Epirubicin market is expected to reach 243.99 million by 2028 from US$ 191.66 million in 2021. The market is estimated to grow at a CAGR of 3.60% from 2022 to 2028.
Epirubicin hydrochloride is a class of drugs termed anthracyclines and is primarily used to treat breast cancers after surgical resection. Anthracyclines are antibiotics isolated from the gram-positive bacteria Streptomyces. They are commonly used as chemotherapy agents and exert…
Epirubicin Market Growth and Recent Trends by Forecast to 2028
According to our latest study, "Epirubicin Market Forecast to 2028 - COVID-19 Impact and Global Analysis - by Dosage, Application, and Distribution Channel," the market was valued at US$ 191.66 million in 2021 and is projected to reach US$ 243.99 million by 2028; it is estimated to grow at a CAGR of 3.60% from 2022 to 2028. The report highlights the key factors driving the market and prominent players with…
